SG10202101247QA - Compositions and methods for the treatment of irritable bowel syndrome - Google Patents
Compositions and methods for the treatment of irritable bowel syndromeInfo
- Publication number
- SG10202101247QA SG10202101247QA SG10202101247QA SG10202101247QA SG10202101247QA SG 10202101247Q A SG10202101247Q A SG 10202101247QA SG 10202101247Q A SG10202101247Q A SG 10202101247QA SG 10202101247Q A SG10202101247Q A SG 10202101247QA SG 10202101247Q A SG10202101247Q A SG 10202101247QA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- treatment
- methods
- bowel syndrome
- irritable bowel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641027529 | 2016-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202101247QA true SG10202101247QA (en) | 2021-03-30 |
Family
ID=61163212
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202101247QA SG10202101247QA (en) | 2016-08-11 | 2017-04-19 | Compositions and methods for the treatment of irritable bowel syndrome |
SG11201900588YA SG11201900588YA (en) | 2016-08-11 | 2017-04-19 | Compositions and methods for the treatment of irritable bowel syndrome |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201900588YA SG11201900588YA (en) | 2016-08-11 | 2017-04-19 | Compositions and methods for the treatment of irritable bowel syndrome |
Country Status (14)
Country | Link |
---|---|
US (2) | US11078154B2 (es) |
EP (1) | EP3481383B1 (es) |
JP (1) | JP2019524796A (es) |
KR (1) | KR20190039723A (es) |
CN (1) | CN109640965A (es) |
AU (1) | AU2017308801B2 (es) |
CA (1) | CA3031893A1 (es) |
IL (1) | IL264467B (es) |
MX (1) | MX2019001360A (es) |
NZ (1) | NZ750126A (es) |
RU (1) | RU2751770C2 (es) |
SG (2) | SG10202101247QA (es) |
WO (1) | WO2018029545A1 (es) |
ZA (1) | ZA201900466B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA53075A (fr) * | 2018-02-02 | 2021-05-12 | Boehringer Ingelheim Int | Dérivés d'oxadiazolopyridine à substitution benzyle, (pyridin-3-yl)méthyle ou (pyridin-4-yl)méthyle utilisés en tant qu'inhibiteurs de la ghréline o-acyltransférase (goat) |
CN113398112A (zh) * | 2021-06-17 | 2021-09-17 | 西南医科大学 | FA介导的BBA/CM-β-CD靶向递药系统、制备方法及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
CN1044364C (zh) * | 1993-06-26 | 1999-07-28 | 河南师范大学 | 一种治疗肠炎和溃疡性结肠炎的药物及其制备工艺 |
IL113459A (en) | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
WO1999021537A1 (fr) | 1997-10-28 | 1999-05-06 | Bando Chemical Industries, Ltd. | Feuille de timbre cutane et procede de production d'une feuille de base pour timbre |
US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
DE19827732A1 (de) | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
US6312716B1 (en) | 1999-05-10 | 2001-11-06 | Peierce Management Llc | Patch and method for transdermal delivery of bupropion base |
US6974588B1 (en) | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
WO2006125293A1 (en) | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
KR101486590B1 (ko) * | 2006-01-05 | 2015-01-26 | 벨로시스 파마슈티컬스 에이/에스 | 붕해성의 충전형 정제 |
SG192488A1 (en) * | 2008-07-08 | 2013-08-30 | Catabasis Pharmaceuticals Inc | Fatty acid acetylated salicylates and their uses |
ES2615204T3 (es) * | 2009-04-06 | 2017-06-05 | Crearene Ltd. | Soluciones para la hemodiálisis y diálisis peritoneal que comprenden uno o más compuestos de creatina |
IT1400119B1 (it) * | 2010-05-24 | 2013-05-17 | Sofar Spa | Nuovi derivati della mesalazina, processo di sintesi ed uso nel trattamento di malattie infiammatorie intestinali. |
US9498461B2 (en) * | 2012-05-23 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014091384A2 (en) * | 2012-12-12 | 2014-06-19 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
US9333187B1 (en) * | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
-
2017
- 2017-04-19 WO PCT/IB2017/052233 patent/WO2018029545A1/en unknown
- 2017-04-19 CN CN201780049248.9A patent/CN109640965A/zh active Pending
- 2017-04-19 JP JP2019506688A patent/JP2019524796A/ja active Pending
- 2017-04-19 SG SG10202101247QA patent/SG10202101247QA/en unknown
- 2017-04-19 MX MX2019001360A patent/MX2019001360A/es unknown
- 2017-04-19 AU AU2017308801A patent/AU2017308801B2/en active Active
- 2017-04-19 NZ NZ750126A patent/NZ750126A/en unknown
- 2017-04-19 SG SG11201900588YA patent/SG11201900588YA/en unknown
- 2017-04-19 EP EP17838873.2A patent/EP3481383B1/en active Active
- 2017-04-19 CA CA3031893A patent/CA3031893A1/en active Pending
- 2017-04-19 US US16/323,069 patent/US11078154B2/en active Active
- 2017-04-19 KR KR1020197005064A patent/KR20190039723A/ko not_active Application Discontinuation
- 2017-04-19 RU RU2019101849A patent/RU2751770C2/ru active
-
2019
- 2019-01-23 ZA ZA2019/00466A patent/ZA201900466B/en unknown
- 2019-01-24 IL IL264467A patent/IL264467B/en unknown
-
2021
- 2021-08-02 US US17/392,087 patent/US20220162156A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3481383B1 (en) | 2023-06-14 |
US20190177267A1 (en) | 2019-06-13 |
RU2751770C2 (ru) | 2021-07-16 |
ZA201900466B (en) | 2020-06-24 |
CN109640965A (zh) | 2019-04-16 |
SG11201900588YA (en) | 2019-02-27 |
KR20190039723A (ko) | 2019-04-15 |
JP2019524796A (ja) | 2019-09-05 |
MX2019001360A (es) | 2019-06-03 |
RU2019101849A3 (es) | 2020-09-11 |
EP3481383A1 (en) | 2019-05-15 |
US20220162156A1 (en) | 2022-05-26 |
RU2019101849A (ru) | 2020-09-11 |
CA3031893A1 (en) | 2018-02-15 |
AU2017308801A1 (en) | 2019-02-07 |
IL264467B (en) | 2021-09-30 |
NZ750126A (en) | 2022-07-01 |
AU2017308801B2 (en) | 2022-03-10 |
EP3481383A4 (en) | 2020-03-18 |
US11078154B2 (en) | 2021-08-03 |
IL264467A (en) | 2019-02-28 |
WO2018029545A1 (en) | 2018-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3347469A4 (en) | METHOD AND COMPOSITIONS FOR TREATING GLAUCOMA | |
ZA201707303B (en) | Compositions and methods for the treatment of immunodeficiency | |
HK1248531A1 (zh) | 免疫調節組合物及其使用方法 | |
ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
HK1250480A1 (zh) | 用於治療hbv感染的組合物和方法 | |
EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
HK1249515A1 (zh) | 預防和治療聽力損失的方法和組合物 | |
SG11201702554QA (en) | Compositions and methods for the treatment of multiple sclerosis | |
HK1246193A1 (zh) | 用於改善認知的方法和組合物 | |
ZA201902781B (en) | Compositions and methods for the treatment of xerostomia | |
IL249640A0 (en) | Preparations for the treatment of nosebleeds | |
HK1257853A1 (zh) | 用於治療和預防放射性皮炎的組合物和方法 | |
EP3368048A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DOSE | |
HK1252057A1 (zh) | 新穎的使用方法和組合物 | |
HK1247136A1 (zh) | 包含15-hepe的組合物和其使用方法 | |
IL251736B (en) | Methods and compositions for the treatment of radiation-related disorders | |
EP3341006A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE | |
ZA201900984B (en) | Methods and compositions for the treatment of warts | |
IL264977A (en) | Methods and preparations for the treatment of melanoma | |
HK1255695A1 (zh) | 用於治療眼瞼下垂的組合物和方法 | |
GB201511799D0 (en) | Composition and methods of treatment | |
PL3113774T3 (pl) | Kompozycje grapiprantu i sposoby ich zastosowania | |
IL264467B (en) | Compounds and methods for the treatment of irritable bowel syndrome | |
GB201621737D0 (en) | Compositions and methods of treatment | |
DK3313207T3 (en) | Compositions and methods for the treatment of malnutrition |